FDA Inspection 618483 — Triax Pharmaceuticals, LLC
The FDA completed an inspection of Triax Pharmaceuticals, LLC on Oct 5, 2009 in Cranford, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 5, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cranford, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)